<DOC>
	<DOCNO>NCT01615640</DOCNO>
	<brief_summary>The aim study assess accuracy dynamic contrast enhance diffusion-weighted MR Imaging evaluate response chemotherapy osteosarcoma .</brief_summary>
	<brief_title>Diffusion Study Patients With Osteosarcoma</brief_title>
	<detailed_description>Dynamic contrast-enhanced diffusion-weighted magnetic resonance image potential measure early cellular vascular change occur response chemotherapy could therefore early predictor therapeutic response . Aim study ass accuracy dynamic contrast enhance diffusion-weighted MR image evaluate response chemotherapy preoperative treatment osteosarcoma . Patients undergo dynamic contrast-enhanced diffusion-weighted magnetic resonance imaging , chemotherapy . Our long-term goal use image technique develop non-invasive methodology would better predictor tumor response current clinical standard earlier predictor histological evaluation whole tumor .</detailed_description>
	<mesh_term>Osteosarcoma</mesh_term>
	<criteria>Histologically confirm diagnosis osteosarcoma entity Written inform consent patient No write informed consent Contraindications MRI ( pacemaker , aneurysm clip , mechanical and/or electrical device metallic fragment , severe claustrophobia ) Severe , active comorbidity Major medical illness psychiatric impairment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Osteosarcoma</keyword>
	<keyword>Response chemotherapy</keyword>
	<keyword>Dynamic contrast medium examination</keyword>
	<keyword>Diffusion-weighted MR imaging</keyword>
</DOC>